Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials

Overview

BridgeBio is a biotechnology company focused on designing transformative medicines for patients with genetic diseases. It employs a novel approach to drug development by integrating finance with science to deliver solutions as efficiently as possible. The company is committed to developing not only life-changing drugs but also leaders in the field, encouraging hands-on engagement and the pursuit of innovation.

News

News markets.businessinsider.com 2 months ago
BridgeBio to Present New Acoramidis Data from Open-Label Extension Analyses in ATTR-CM at ESC Congress 2026
PALO ALTO, Calif., Aug. 24, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (
Read more
Report
Report
Press release Nasdaq 5 months ago
BridgeBio to Participate in May and June Investor Conferences
--BridgeBio Pharma, Inc., a biopharmaceutical company focused on developing medicines for genetic conditions, today announced that members of its management team will participate in fireside chats at the following healthcare investor conferences:. BofA Se
Read more
Report
Press release Nasdaq 11 months ago
BridgeBio to Participate in December Investor Conferences
--BridgeBio Pharma, Inc., a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will participate in fireside chats at the following healthcare investor conferences:. Piper Sandler Healthca
Read more
Report
Press release Nasdaq 12 months ago
BridgeBio to Report Phase 3 Results for Small Molecule BBP-418 in LGMD2I/R9 FORTIFY Study, along with Third Quarter 2025 Financial Results Next Week
--BridgeBio Pharma, Inc., a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will host two separate business update calls to share the following:. Limb-girdle Muscular Dystrophy Type 2
Read more
Report
Show more news

Tech stack

Technologies named in job postings at Bridgebio over the last 12 months, by layer, with the share of postings for each.
Technologies in use
4
Postings analysed
2
Stack modernity
90/100AI adopter
Languages
Python
AI & ML
Claude
Practices & domains
AI Agents
Machine Learning
Sign in to see how your skills match this stack Sign In

Salary insights

Compensation ranges based on this company's open jobs
Median
$193k
Typical range
$180k – $205k
Open positions
2
2 Jobs
Senior 100%
Level Jobs Median Typical range
Senior 2 $193k $180k – $205k
Highest paying role Senior Biological Data Scientist $205k
Normalized to USD per year

Growth

Hiring Momentum
44/100
Stable
Open positions
3
1 opened / 0 closed in 30 days
Hiring Dynamics 0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Data Science
33% ▲
Operations
33% ▲
Science & Research
33% ▲

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
San Francisco
San Francisco United States
Regional office
3 open roles 3 posted in 90 days 67% engineering $193k Avg Salary
hires for Data Science, Operations, Science & Research
seen since Oct 2026

Jobs

$155k – $205k per year • Hybrid • Full-Time • 5+ years exp • San Francisco
Python
AI Agents
Apply